| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.5 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.5 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | sotrastaurin | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.5 |